Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Cancer Research|April 18, 2024
CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell LymphomaXiyue Xu, Yidan Zhang, Yaxiao Lu, et al.
International Journal of Cancer|January 22, 2019
Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcomeXianhuo Wang, Tingting Zhang, Zheng Song, et al.
British Journal of Haematology|March 6, 2024
Epidemiological features and prognosis for primary gastrointestinal follicular lymphomaXuelei Li, Fenghua Gao, Xiangrui Meng, et al.
Hematological Oncology|March 19, 2025
Survival Benefit of Relmacabtagene Autoleucel Versus Usual Care in Relapsed/Refractory Follicular Lymphoma: A Matching-Adjusted Indirect AnalysisFenghua Gao, Cong Sun, Jing Liu, et al.
The Lancet. Haematology|June 30, 2022
SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trialYuqin Song, Yanyan Liu, Zhi-Ming Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 10, 2018
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCLLinyu Li, Xuhan Zhang, Tingting Zhang, et al.
Leukemia|April 15, 2025
Molecular landscape of distinct follicular lymphoma histologic grades: insights from genomic and transcriptome analysesCong Sun, Wei Li, Jingwei Yu, et al.
Signal Transduction and Targeted Therapy|July 20, 2025
Differential expression pattern of CC chemokine receptor 7 guides precision treatment of hepatocellular carcinomaJie Qin, Qianyi Gong, Cheng Zhou, et al.
Hematological Oncology|December 6, 2024
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort StudyPeiqi Zhao, Shu Zhao, Chen Huang, et al.
Hematological Oncology|July 8, 2025
Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim <sup>18</sup>F-FDG PET-CT Analysis and the NCCN-IPI: A Multicenter Retrospective StudyJiesong Wang, Yong Sun, Meifu Lin, et al.
Pageof 19